Clinical Trials Browser

Phase 1/2 × Solid Tumors, Adult × 30 days × Clear all

NCT07228247 2026-05-27

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors, Adult